United States News Todas as matérias

Accenture (NYSE:ACN) has officially closed its acquisition of Faculty, a premier UK-based artificial intelligence company recognized for its expertise in AI safety and large-scale implementation.

Micron Technology (NASDAQ:MU) announced on March 15, 2026, the formal completion of its acquisition of the P5 Tongluo site from Powerchip Semiconductor Manufacturing (PSMC).

Zepp Health (NYSE:ZEPP) reported a 43% year-over-year increase in fourth-quarter revenue, reaching $85.2 million and meeting the high end of its previous guidance.

United States regulators have released new guidance aimed at strengthening oversight of the fast-growing prediction markets sector as trading in event-based derivatives continues to expand.

Immutep (NASDAQ:IMMP) announced on March 13, 2026, that it will shut down its Phase III TACTI-004 clinical trial evaluating eftilagimod alpha ("efti") in combination with anti-PD-1 therapy for first-line non-small cell lung cancer (NSCLC).

Trinseo (NYSE:SE) reported a net loss of $546 million for the full year 2025, a result heavily impacted by $140 million in pre-tax restructuring charges and the costs associated with a comprehensive debt refinancing completed in early 2025.

Honda Motor Company (NYSE:HMC) announced a drastic retrenchment of its electrification strategy on Friday, canceling the development and production of three core electric vehicles slated for the North American market.

Recon Technology (NASDAQ:RCON) reported a significant improvement in its financial performance for the first six months of fiscal year 2026, ending December 31, 2025.

Dynagas LNG Partners (NYSE:DLNG) reported a net income of $61.6 million for the full year 2025, reflecting the continued strength of the global liquefied natural gas (LNG) shipping market.

Barinthus Biotherapeutics (NASDAQ:BRNS) has entered into a proposed all-stock business combination with Clywedog, a strategic move aimed at consolidating resources and advancing a diversified immunotherapy pipeline.

Maiden Holdings (NASDAQ:MHLD), the Hamilton, Bermuda-based reinsurance holding company, reported a net loss of $17.8 million for the fourth quarter of 2025.

Purple Biotech (NASDAQ:PPBT) posted a net loss of $26.4 million for the full year 2025, a result heavily impacted by a $20.5 million non-cash impairment of its CM24 and NT219 programs.

Xenetic Biosciences (NASDAQ:XBIO) reported a 19% increase in royalty revenue for the full year 2025, providing a financial cushion as the company moves closer to human clinical trials for its lead immuno-oncology program.

bioAffinity Technologies (NASDAQ:BIAF) reported fiscal year 2025 results that underscore an aggressive transition from a broad laboratory service model to a specialized, high-growth diagnostic powerhouse focused on early-stage lung cancer detection.

Savara (NASDAQ:SVRA) provided a year-end financial update that underscores the company’s transition toward the commercial stage, with increased spending on pre-launch activities for its lead drug candidate, molgramostim.

Kestrel Group (NASDAQ:KG) delivered a bifurcated set of results for its fiscal year ended December 31, 2025, characterized by a massive surge in its fee-based business and a heavy fourth-quarter net loss due to specific one-time accounting charges.

Acurx Pharmaceuticals (NASDAQ:ACXP) on Friday reported a full-year 2025 net loss of $8 million, with cash and cash equivalents of $7.6 million as of December 31, 2025, supported by approximately $4 million in gross proceeds from its equity line of credit during the year.

AC Immune (NASDAQ:ACIU) unveiled clinical data on Friday suggesting its experimental vaccine could potentially slow the progression of Parkinson’s disease, a milestone that accompanied a significant corporate restructuring aimed at preserving its capital.

The ONE Group Hospitality (NASDAQ:STKS) reported a complex fourth quarter for fiscal 2025, marked by a strategic contraction of its portfolio and a calendar shift that dampened its traditional holiday revenue peak.

Better Home & Finance Holding Company (NASDAQ:BETR) delivered a sharp increase in operational momentum for the fourth quarter of 2025, signaling that its AI-native mortgage platform is beginning to capture significant market share as the interest rate environment shifts.

Douglas Elliman (NYSE:DOUG) turned a corner in fiscal 2025, moving from a steep loss to a net profit.

Waldencast (NASDAQ:WALD) reported a transformative finish to fiscal year 2025, prioritizing balance sheet stability through a series of strategic divestitures and debt restructurings while navigating mixed performance across its core brand portfolio.

The Buckle (NYSE:BKE) delivered a solid conclusion to its 2025 fiscal year, posting gains in both top-line revenue and net income as the denim-focused retailer continues to navigate a shifting consumer landscape.

Voyager Acquisition (NASDAQ:VACH) moved one step closer to finalizing its merger with Veraxa Biotech following an extraordinary general meeting on March 12, 2026.